The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing (20 - 21) Manufacture of chemicals and pharmaceuticals 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations 21.10 - Manufacture of basic pharmaceutical products
145 jobs Number of planned job creations
Announcement Date
11 September 2019
Employment effect (start)
2 September 2019
Foreseen end date
4 November 2019
Description
Salvus, Croatian pharmaceuticals and medical products company, announced the creation of 145 new jobs. The company has reported that it has invested over HRK 50million (€6.73 million) in its new head centre in Donja Stubica, not far from the Capital of Zagreb. The construction and equipping of the centre have been co-financed by the European Fund for Regional Development.
With this investment and business expansion, Salvus wants to strengthen its efficiency and increase its competitiveness on both the domestic and foreign markets. The company already operates across six markets in Croatia, Slovenia, Serbia, Bosnia and Herzegovina, Albania and Kosovo. Salvus's aim is to connect pharmaceuticals' local tradition with modern technology and scientific advances. The company plans to start production of its own portfolio of products to enter the global market.
Eurofound (2019), Salvus, Business expansion in Croatia, factsheet number 98607, European Restructuring Monitor. Dublin, https://apps.eurofound.europa.eu/restructuring-events/detail/98607.